Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2.
about
Mechanism and significance of cell type-dependent neutralization of flavivirusesDengue virus selectively induces human mast cell chemokine productionFlavivirus cell entry and membrane fusionPrM- and cell-binding domains of the dengue virus E protein.Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil lineMonoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero CellsCharacterization of a siberian virus isolated from a patient with progressive chronic tick-borne encephalitis.Demonstration of binding of dengue virus envelope protein to target cellsActivation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytesCharacterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking.Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 VirusDifferential Modulation of prM Cleavage, Extracellular Particle Distribution, and Virus Infectivity by Conserved Residues at Nonfurin Consensus Positions of the Dengue Virus pr-M JunctionMolecular mechanisms of antibody-mediated neutralisation of flavivirus infectionStructural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine DevelopmentA Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within EndosomesGenetic diversity of the E Protein of Dengue Type 3 VirusDeconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and ImmunityStructure of the St. Louis Encephalitis Virus Postfusion Envelope TrimerCrystal Structure of the Japanese Encephalitis Virus Envelope ProteinA Japanese Encephalitis Virus Vaccine Inducing Antibodies Strongly Enhancing In Vitro Infection Is Protective in PigsIdentification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implicationsInfluence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles.RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection.West Nile virus infection causes endocytosis of a specific subset of tight junction membrane proteins.Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop.Interleukin-1alpha released from epithelial cells after adenovirus type 37 infection activates intercellular adhesion molecule 1 expression on human vascular endothelial cellsAutophagy facilitates antibody-enhanced dengue virus infection in human pre-basophil/mast cells.Antibody-mediated neutralization of flaviviruses: a reductionist view.Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition.A Molecular Approach Designed to Limit the Replication of Mature DENV2 in Host Cells.Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue viruses.A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection.Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development.Characterization of two monoclonal antibodies, 38F10 and 44D11, against the major envelope fusion protein of Helicoverpa armigera nucleopolyhedrovirus.The capsid-binding nucleolar helicase DDX56 is important for infectivity of West Nile virus.Virus antibody dynamics in primary and secondary dengue infections.Alteration of virus entry mode: a neutralisation mechanism for Dengue-2 virus.Functions of Antibodies.Unmutated immunoglobulin M can protect mice from death by influenza virus infection.
P2860
Q23032973-4AED07BF-9501-4633-BAD7-B4D19B19755FQ24673736-E7CD4924-D256-460A-8878-1AF3D5025A3FQ26852458-B118350E-E016-4A1A-B1AD-DF57B351DE8DQ27469382-4E91B4F0-6C54-49E4-970E-8D5697FAE10EQ27469685-94FEDE6B-9642-46B0-A44A-3CD7A965DA48Q27469935-D598152D-E06A-4A2D-BAF6-762DCD1B235DQ27473070-595CAEB8-DB6E-47E0-8EEF-F3E429B2C3DEQ27480760-982708D7-AEBB-429C-85A2-38376FD08BF4Q27480826-0E6D7C75-7180-48E6-AB04-5BC6C6C0DA32Q27484978-8C7EEA89-033E-428B-8881-65EBFFD0DB1FQ27486788-02856B77-BED5-42A4-BCA3-00B0795D43CEQ27487116-CA44E514-6AC5-4AA7-8002-BFA565D45A4FQ27488337-F667F982-DF6F-4562-A77D-3B4B7ADA0962Q27488364-FD25AFA8-4421-4582-92F4-17EC3A292FD4Q27488367-0FF89E18-BE52-44D8-8507-B5B2B3C57A81Q27489081-4433BEC3-4796-4306-86F1-946D45360606Q27654848-4BBDF6AD-F093-42DD-89D9-6CD8B6CFA7BAQ27674868-EC2908FA-04F1-433C-A1D5-5C7F2CA59F9BQ27676100-2A11BA71-5E45-43FE-B6D5-23FBD5C28FA7Q30250935-66FADFD9-2DD2-4C59-909A-93AB0AC7DE58Q33469751-C6D7BC70-5E71-4C0C-BD01-28B9C4AD9EF0Q34046013-D29147C3-030B-433F-A9AF-61031169C24DQ34222029-AC25AB22-366E-4AA6-9BA5-99AF4DEFE43CQ34289114-AA63F6B5-B34F-4451-9D5F-C943D29BB591Q34306877-227AC128-72ED-45CB-99AA-2DDE3E1B1D24Q34327277-DE462C33-A6D3-409E-9F6E-69CA14084D20Q34352267-3F2A9A93-7D54-4847-97B4-B21142316DA6Q34999617-FF3E11A8-C673-400E-AFDD-79F2949D430EQ35947703-63FEF0B6-793B-4915-9692-9D860447CAD7Q36030328-A4C8A820-2D08-4A3F-93D3-0E68BA1F05DDQ36953896-2504059E-83AC-48BE-A4CE-CCD54D3615A5Q37012203-2563600B-C189-4138-BBC8-88720F3A6C23Q38636217-D2B96374-3477-47DD-BC72-3E8EDB48BDBCQ38725341-D7D73B0E-B72F-4A50-8379-41B0A899B98DQ39575246-95776B3D-4421-4AD8-85C0-A985327DB6BBQ40222559-490B6449-55E4-43F4-B6CA-41A2543A1177Q40612834-D53AB08A-E9B1-4ACC-A414-6542AE540C86Q41741684-0F08C345-5328-428E-B6E8-1D9C858B2B1EQ41966856-A17AA510-99E8-4BE5-A6D0-26F937E7395B
P2860
Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Antibodies that block virus at ...... e against dengue virus type 2.
@en
type
label
Antibodies that block virus at ...... e against dengue virus type 2.
@en
prefLabel
Antibodies that block virus at ...... e against dengue virus type 2.
@en
P2093
P356
P1476
Antibodies that block virus at ...... e against dengue virus type 2.
@en
P2093
Anderson R
Kalayanarooj S
Usawattanakul W
P2860
P304
P356
10.1002/JMV.1890450417
P577
1995-04-01T00:00:00Z